Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis

Overview of attention for article published in Annals of the Rheumatic Diseases, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 2 news outlets
policy: 2 policy sources

twitter: 16 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 164 Dimensions

Readers on

mendeley: 152 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 19 X posts from 16 X users, with an upper bound of 49,743 followers.

REMAIN(2017) Annals of Rheum Dis. Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis 維持期間 AZA維持治療を診断24ヶ月で中止すると48ヶ月群と比べて再燃率悪化 https://t.co/HYJkB65JKD

02 Mar 2023

Reply Repost Favourite

RT @reumatuits: #Vasculitis ¿Por cuánto tiempo prolongar terapia de mantenimiento en vasculitis ANCA? 🤷‍♂️CON AZATIOPRINA: mejor 48 que 24…

16 May 2018

Reply Repost Favourite

RT @reumatuits: #Vasculitis ¿Por cuánto tiempo prolongar terapia de mantenimiento en vasculitis ANCA? 🤷‍♂️CON AZATIOPRINA: mejor 48 que 24…

16 May 2018

Reply Repost Favourite

#Vasculitis ¿Por cuánto tiempo prolongar terapia de mantenimiento en vasculitis ANCA? 🤷‍♂️CON AZATIOPRINA: mejor 48 que 24 meses (estudio REMAIN extendido 👉https://t.co/Q0iDO4knt9)

15 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.